These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A hapten model of topically-induced ocular anaphylaxis in the rat. Trocmé SD; Bonini S; Trocmé MC; Barney NP; Bloch KJ; Allansmith MR Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):264-9. PubMed ID: 8591906 [TBL] [Abstract][Full Text] [Related]
5. Clinical and cytologic aspects of ocular late-phase reaction in the guinea pig. Saiga T; Briggs RM; Allansmith MR Ophthalmic Res; 1992; 24(1):45-50. PubMed ID: 1376886 [TBL] [Abstract][Full Text] [Related]
6. Tear volume in early and late phases of ocular anaphylaxis in guinea pigs. Saiga T; Allansmith MR Ophthalmic Res; 1991; 23(6):335-41. PubMed ID: 1803315 [TBL] [Abstract][Full Text] [Related]
7. Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat. Trocmé SD; Bonini S; Barney NP; Bloch KJ; Allansmith MR Acta Ophthalmol (Copenh); 1988 Feb; 66(1):24-32. PubMed ID: 3364167 [TBL] [Abstract][Full Text] [Related]
8. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Allansmith MR; Baird RS; Ross RN; Barney NP; Bloch KJ Acta Ophthalmol Suppl (1985); 1989; 192():145-53. PubMed ID: 2554644 [TBL] [Abstract][Full Text] [Related]
9. Early and late phases of ocular anaphylaxis in actively immunized guinea pigs. Calonge M; Briggs RM; Levene RB; Saiga T; Bloch KJ; Allansmith MR Acta Ophthalmol (Copenh); 1990 Aug; 68(4):470-6. PubMed ID: 1699390 [TBL] [Abstract][Full Text] [Related]
10. Allergen dose response and late symptoms in a human model of ocular allergy. Bonini S; Bonini S; Bucci MG; Berruto A; Adriani E; Balsano F; Allansmith MR J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):869-76. PubMed ID: 2262643 [TBL] [Abstract][Full Text] [Related]
11. Penetrating the conjunctival barrier. The role of molecular weight. Kahn M; Barney NP; Briggs RM; Bloch KJ; Allansmith MR Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):258-61. PubMed ID: 2303328 [TBL] [Abstract][Full Text] [Related]
12. Vascular permeability during the early and late phases of ocular anaphylaxis. Calonge M; Ng B; Allansmith MR; Bloch KJ Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):55-9. PubMed ID: 1730548 [TBL] [Abstract][Full Text] [Related]
13. Conjunctival mast cells and the allergic late phase reaction. Leonardi A; Secchi AG; Briggs R; Allansmith MR Ophthalmic Res; 1992; 24(4):234-42. PubMed ID: 1279495 [TBL] [Abstract][Full Text] [Related]
15. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye. Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127 [TBL] [Abstract][Full Text] [Related]